Human Papillomavirus Vaccination Among Young Adults Before and During the COVID-19 Pandemic

Kalyani Sonawane; Ashvita Garg; Eric G Meissner; Haluk Damgacioglu; Elizabeth Hill; Alan G Nyitray; Ashish A Deshmukh

doi:10.1001/jamanetworkopen.2023.56875

Human Papillomavirus Vaccination Among Young Adults Before and During the COVID-19 Pandemic

JAMA Netw Open. 2024 Feb 5;7(2):e2356875. doi: 10.1001/jamanetworkopen.2023.56875.

Authors

Kalyani Sonawane^{1

2}, Ashvita Garg^{1

2}, Eric G Meissner³, Haluk Damgacioglu^{1

2}, Elizabeth Hill^{1

2}, Alan G Nyitray⁴, Ashish A Deshmukh^{1

2}

Affiliations

¹ Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston.
² MUSC Hollings Cancer Center, Charleston, South Carolina.
³ Department of Medicine, College of Medicine, Medical University of South Carolina, Charleston.
⁴ Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee.

No abstract available

Plain language summary

This cross-sectional survey study assesses the self-reported human papillomavirus vaccination rate by sociodemographic characteristics in adults aged 18 to 26 years from 2018 to 2022.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

COVID-19* / epidemiology
COVID-19* / prevention & control
Human Papillomavirus Viruses
Humans
Pandemics / prevention & control
Papillomavirus Infections* / epidemiology
Papillomavirus Infections* / prevention & control
Papillomavirus Vaccines* / therapeutic use
Vaccination
Young Adult

Substances

Papillomavirus Vaccines

Plain language summary

Publication types

MeSH terms

Substances

Grants and funding